List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Categories
Countries
UNITED STATES SPECIALTY GENERICS MARKET: INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 93 pages | Published: 04-08-2019 |
- Healthcare
- IMARC GROUP
- 93 pages
- Published: 04-08-2019
The United States Specialty Generics Market reached a value of US$ 18.4 Billion in 2018. Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.
Specialty generics are economical compared to specialty drugs as they don’t need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, as per the American cancer society, a total of 1,762,450 new cancer cases and 606,880 deaths from cancer are expected to occur in the United States in 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years. Looking forward, IMARC Group expects the market value to reach US$ 32.6 Billion by 2024, exhibiting a CAGR of around 10% during 2019-2024
Report Scope:
Historical, Current and Future Market Trends
Market Breakup by Route of Administration:
Injectables
Oral
Others
Market Breakup by Indication:
Oncology
Autoimmune Diseases
Infectious Diseases
Others
Market Breakup by Distribution channel:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Competitive Landscape:
The leading players in the US specialty generics industry have also been examined in the report.
Key Questions Answered in This Report:
- How has the US specialty generics market performed so far and how will it perform in the coming years?
- What is the breakup of the US specialty generics market based on the route of administration
- What is the breakup of the US specialty generics market based on the indication?
- What is the breakup of the US specialty generics market based on the distribution channel?
- What are the various stages in the value chain of the US specialty generics industry?
- What are the key driving factors and challenges in the US specialty generics market?
- What is the structure of the US specialty generics industry and who are the key players?
- What is the degree of competition in the US specialty generics market?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Global Specialty Generics Market: Introduction 4.1 What are Specialty Generic Drugs? 4.2 Types of Specialty Generics 5 Why are Specialty Generics So Lucrative? 6 Global Specialty Generics Market 6.1 Market Overview 6.2 Market Performance 6.3 Market Breakup by Route of Administration 6.4 Market Breakup by Indication 6.5 Market Breakup by Distribution Channel 6.6 Market Breakup by Region 6.7 Market Forecast 7 US Specialty Generics Market 7.1 Market Overview 7.2 Market Performance 7.3 Market Breakup by Route of Administration 7.4 Market Breakup by Indication 7.5 Market Breakup by Distribution Channel 7.6 Market Forecast 7.7 SWOT Analysis 7.7.1 Overview 7.7.2 Strengths 7.7.3 Weaknesses 7.7.4 Opportunities 7.7.5 Threats 7.8 Value Chain Analysis 7.9 Porters Five Forces Analysis 7.9.1 Overview 7.9.2 Bargaining Power of Buyers 7.9.3 Bargaining Power of Suppliers 7.9.4 Degree of Competition 7.9.5 Threat of New Entrants 7.9.6 Threat of Substitutes 7.10 Key Market Drivers and Success Factors 8 Market Breakup by Route of Administration 8.1 Injectables 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Oral 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.1 Market Forecast 9 Market Breakup by Indication 9.1 Oncology 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Autoimmune Diseases 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Infectious Diseases 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Distribution Channel 10.1 Retail Pharmacies 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Specialty Pharmacies 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Hospital Pharmacies 10.3.1 Market Trends 10.3.2 Market Forecast 11 Competitive Landscape 11.1 Market Structure 11.2 Key Players 11.3 Profiles of Key Players |
Market Breakup by Route of Administration
- Injectables
- Oral
- Others
Market Breakup by Indication
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Others
Market Breakup by Distribution Channel
- Retail Pharmacies
- Specialty Pharmacies
- Hospital Pharmacies
TRAVEL VACCINES MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 120 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 120 pages
- Published: 02-11-2019
The global travel vaccines market was worth US$ 4.9 Billion in 2018. Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future.
The number of international tourist arrivals worldwide increased from around 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers traveled from developed countries to regions with endemic diseases. As more people travel to countries with endemic disease, demand for vaccinations will continue to increase. Morever, regulatory authorities across the globe have also mandated that travelers should be vaccinated before travelling to disease-prone regions. As a result, travel vaccines have now become an important requirement in an international travelers list. For instance, The Ministry of Health in the kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis, Poliomyelitis, etc. must present a valid vaccination certificate. Other factors driving the demand of travel vaccines include increasing awareness levels, technological advancements, increasing incidence of life-threatening infectious diseases, etc. Looking forward, we expect the global travel vaccine market to reach a value of US$ 8.1 billion by 2024, exhibiting a CAGR of around 9% during 2019-2024.
Market Summary:
Based on the composition, the market has been segmented into mono vaccines and combination vaccines.
Based on the disease, the market has been segmented into hepatitis A, hepatitis B, Japanese encephalitis vaccines, meningococcal, rabies, typhoid, yellow fever and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global sales.
The competitive landscape of the market has also been examined with some of the key players being GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, ALK-Abelló, Bavarian Nordic, Crucell N.V., CSL Limited, MedImmune, LLC, Altimmune, Abbott Laboratories and F. Hoffman-La Roche Ltd.
Key Questions Answered in This Report:
- How has the global travel vaccines market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global travel vaccines industry?
- What is the breakup of the global travel vaccines market on the basis of composition?
- What is the breakup of the global travel vaccines market on the basis of disease?
- What are the various stages in the value chain of the global travel vaccines market?
- What are the key driving factors and challenges in the global travel vaccines market?
- What is the structure of the global travel vaccines market and who are the key players?
- What is the degree of competition in the global travel vaccines market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global Travel Vaccines Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Composition 5.4 Market Breakup by Disease 5.5 Market Breakup by Region 5.6 Market Forecast 6. Market Breakup by Composition 6.1 Mono Vaccines 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Combination Vaccines 6.2.1 Market Trends 6.2.2 Market Forecast 7. Market Breakup by Disease 7.1 Hepatitis A 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Hepatitis B 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Japanese Encephalitis Vaccines 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Meningococcal 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Rabies 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Typhoid 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Yellow Fever 7.7.1 Market Trends 7.7.2 Market Forecast 7.8 Others 7.8.1 Market Trends 7.8.2 Market Forecast 8. Market Breakup by Region 8.1 North America 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Europe 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Asia Pacific 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Middle East and Africa 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Latin America 8.5.1 Market Trends 8.5.2 Market Forecast 9. Global Travel Vaccines Industry: SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10. Global Travel Vaccines Industry: Value Chain Analysis 10.1 Exploratory Stage 10.2 Preclinical and Clinical Development 10.3 Regulatory Approval 10.4 Manufacturing 10.5 Marketing and Distribution 11. Global Travel Vaccines Industry: Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12. Global Travel Vaccines Industry: Price Analysis 13. Travel Vaccines Manufacturing Process 13.1 Product Overview 13.2 Raw Material Requirements 13.3 Manufacturing Process 13.4 Key Success and Risk Factors 14. Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 GlaxoSmithKline 14.3.2 Sanofi Pasteur 14.3.3 Merck 14.3.4 Novartis 14.3.5 Pfizer 14.3.6 ALK-Abelló 14.3.7 Bavarian Nordic 14.3.8 Crucell N.V. 14.3.9 CSL Limited 14.3.10 MedImmune, LLC 14.3.11 Altimmune 14.3.12 Abbott Laboratories 14.3.13 F. Hoffman-La Roche Ltd. |
Market Breakup by Composition
- Mono Vaccines
- Combination Vaccines
Market Breakup by Disease
- Hepatitis A
- Hepatitis B
- Japanese Encephalitis Vaccines
- Meningococcal
- Rabies
- Typhoid
- Yellow Fever
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
SAUDI ARABIA IN-VITRO DIAGNOSTICS (IVD) MARKET: INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 85 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 85 pages
- Published: 02-11-2019
The Saudi Arabia in-vitro diagnostics (IVD) market was worth US$ 650 Million in 2018. Saudi Arabia currently represents the largest market for in-vitro diagnostics in the GCC region. In-vitro diagnostics, plays a significant role in in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, which enables improved monitoring and treatment. Diagnostics represent only a small share of the total healthcare spending but are critical in medical decision making and reducing the burden of diseases and healthcare expenditures.
There has been a steady growth in the adoption of in-vitro diagnostics in Saudi Arabia. Increasing incidence rates of various infectious and chronic diseases represent some of the key drivers of the in-vitro diagnostics market in Saudi Arabia. The country’s population is currently around 33 Million and is growing annually at around 2%. According to Saudi Arabia’s General Authority of Statistics, elderly constituted 4.2% of the total Saudi population and are expected to increase further in the coming years. With an increasing elderly population, we expect the prevalence of a number of chronic diseases to increase significantly in the next few years. Moreover, catalyzed by rising physical inactivity and consumption of unhealthy diets, the prevalence of a number of lifestyle diseases have been increasing in the country. Saudi Arabia has one of the highest rates of obesity in the world. It is estimated that around 36% of the total population are obese. Additionally, the prevalence of hypertension was around 29% among males and around 24% among females. Saudi Arabia also has one of the highest prevalence of diabetes with around 19% of the adult population suffering from diabetes in the country. Some of the other factors catalyzing the growth of in-vitro diagnostics in Saudi Arabia include rising healthcare expenditures, improving healthcare infrastructure, initiatives by the government, rising awareness levels, etc. Looking forward, the market is further projected to reach a value of US$ 1,020 Million by 2024, growing at a CAGR of around 8% during 2019-2024.
Report Summary
Breakup by Application:
On the basis of application, the market has been segmented into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology, autoimmune diseases and others.
Breakup by End-User:
Based on end-user, the report finds that hospital-based centers currently represent the leading end-user of in-vitro diagnostics in Saudi Arabia. Hospital-based centers are followed by diagnostic chains, standalone centers and others (patient self-testing, academic institutes, etc.)
Competitive Landscape:
The report also provides the competitive landscape and the profiles of key players operating in this market.
This report provides a deep insight into the Saudi Arabia in-vitro diagnostics (IVD) devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Saudi Arabia in-vitro diagnostics (IVD) market in any manner.
Key Questions Answered in This Report:
- How has the Saudi Arabia in-vitro diagnostics (IVD) market performed so far and how will it perform in the coming years?
- What are the key application segments in the Saudi Arabia in-vitro diagnostics (IVD) market?
- What are the major end-users in the Saudi Arabia in-vitro diagnostics (IVD) market?
- What are the various stages in the value chain of the Saudi Arabia in-vitro diagnostics (IVD) market?
- What are the key driving factors and challenges in the Saudi Arabia in-vitro diagnostics (IVD) market?
- What is the degree of competition in the Saudi Arabia in-vitro diagnostics (IVD) market?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Saudi Arabia In-Vitro Diagnostics Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by End-User 5.4 Market Breakup by Application 5.5 Market Forecast 5.6 SWOT Analysis 5.6.1 Overview 5.6.2 Strengths 5.6.3 Weaknesses 5.6.4 Opportunities 5.6.5 Threats 5.7 Value Chain Analysis 5.8 Porters Five Forces Analysis 5.8.1 Overview 5.8.2 Bargaining Power of Buyers 5.8.3 Bargaining Power of Suppliers 5.8.4 Degree of Competition 5.8.5 Threat of New Entrants 5.8.6 Threat of Substitutes 6 Market Breakup by End-User 6.1 Hospital-Based Centres 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Diagnostics Chains 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Standalone Centres 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Application 7.1 Infectious Diseases 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Diabetes 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Blood Test 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Nephrology 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Cardiology 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Oncology 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Autoimmune Diseases 7.7.1 Market Trends 7.7.2 Market Forecast 7.8 Others 7.8.1 Market Trends 7.8.2 Market Forecast 8 Competitive Landscape |
Market Breakup by End-User
- Hospital-Based Centres
- Diagnostics Chains
- Standalone Centres
- Others
Market Breakup by Application
- Infectious Diseases
- Diabetes
- Blood Test
- Nephrology
- Cardiology
- Oncology
- Autoimmune Diseases
- Others
ORTHOPEDIC BRACES AND SUPPORTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 122 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 122 pages
- Published: 02-11-2019
The global orthopedic braces and supports market was worth US$ 3.8 Billion in 2018. Braces and supports are orthopedic equipment which are used externally for holding, aligning, correcting and supporting certain parts of the body while healing from an injury. They are manufactured using specialized materials with intelligent designs that offer intense targeted support to the knee, spine, foot, ankle, upper elbow, shoulder, hip and other body parts. Braces and supports also aid in safeguarding joints after surgeries and offer a sense of mobility to the patients suffering from musculoskeletal problems. Looking forward, the market value is projected to reach US$ 4.9 Billion by 2024, growing at a CAGR of 4.5% during 2019-2024.
Global Orthopedic Braces and Supports Market Drivers:
In comparison with invasive treatments, braces and supports are less painful, assist in quick recovery and reduce the incidences of post-surgical complications. On account of these factors, orthopedic braces and supports are preferred by patients worldwide.
Nowadays, consumers spend a significant part of their day in front of PCs, TVs and smart devices which result in the development of minor and major musculoskeletal deformities and dysfunctions. As a result, the demand for braces and supports is proliferating at a healthy rate.
The geriatric population is at a relatively higher risk of developing spondylitis, osteoarthritis, degenerative disc disease, and other mobility issues. Therefore, the growing elderly population is also contributing to the sales of braces and supports across the globe.
Manufacturers are developing pliable braces with a simplified user-interface, considering the requirements of consumers. They are also incorporating Velcro instead of laces to enable easy application and pulley systems in lumbar supports to allow easy customization.
Technological advancements have led to significant improvements in modeling and material technology and increased flexibility, contouring, and utilization of low-weight materials. Innovations have also led to the incorporation of advanced data sensors and synchronization systems.
Market Summary:
Based on the product, the market has been segmented into lower extremity braces and supports; spinal braces and supports; and upper extremity braces and supports.
Based on the type, the market has been segmented into soft and elastic braces and supports; hinged braces and supports; and hard and rigid braces and supports. Soft and elastic braces and supports currently have the highest share.
Based on the application, the market has been segmented into ligament injury, preventive care, post-operative rehabilitation, osteoarthritis and others. Ligament injury currently accounts for the highest share.
Based on the end-user, the market has been segmented into orthopedic clinics; hospitals and surgical centers; over-the-counter (OTC) platforms; and others. Orthopedic clinics currently account for the highest share.
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.
The competitive landscape of the market has also been examined with some of the key players being Breg, Inc., Össur Hf, Bauerfeind AG, BSN Medical, DJO Finance LLC, 3M Company, Otto Bock Healthcare, Deroyal Industries, Inc., Medi GmbH & Co. KG, Thuasne Group, Alcare Co., Ltd, Zimmer Biomet Holdings, Inc., Trulife, Remington Products Company and Bird & Cronin.
Key Questions Answered in This Report:
- How has the global orthopedic braces and supports market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global orthopedic braces and supports industry?
- What is the breakup of the global orthopedic braces and supports market on the basis of product?
- What is the breakup of the global orthopedic braces and supports market on the basis of type?
- What is the breakup of the global orthopedic braces and supports market on the basis of application?
- What is the breakup of the global orthopedic braces and supports market on the basis of end-user?
- What are the various stages in the value chain of the global orthopedic braces and supports market?
- What are the key driving factors and challenges in the global orthopedic braces and supports market?
- What is the structure of the global orthopedic braces and supports market and who are the key players?
- What is the degree of competition in the global orthopedic braces and supports market?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Orthopedic Braces and Supports Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product 5.4 Market Breakup by Type 5.5 Market Breakup by Application 5.6 Market Breakup by End-User 5.7 Market Breakup by Region 5.8 Market Forecast 6 Market Breakup by Product 6.1 Lower Extremity Braces and Supports 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Spinal Braces and Supports 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Upper Extremity Braces and Supports 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Type 7.1 Soft and Elastic Braces and Supports 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Hinged Braces and Supports 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Hard and Rigid Braces and Supports 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Ligament Injury 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Preventive Care 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Post-Operative Rehabilitaion 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Osteoarthritis 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End-User 9.1 Orthopedic Clinics 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Hospitals and Surgical Centers 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Over-the-Counter (OTC) Platforms 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Asia Pacific 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Europe 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Middle East and Africa 10.4.1 Market Trends 10.4.2 Market Forecast 10.5 Latin America 10.5.1 Market Trends 10.5.2 Market Forecast 11 Global Orthopedic Braces and Supports Industry: SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Global Orthopedic Braces and Supports Industry: Value Chain Analysis 13 Global Orthopedic Braces and Supports Industry: Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Global Orthopedic Braces and Supports Industry: Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Breg, Inc. 15.3.2 Össur Hf 15.3.3 Bauerfeind AG 15.3.4 BSN Medical 15.3.5 DJO Finance LLC 15.3.6 3M Company 15.3.7 Otto Bock Healthcare 15.3.8 Deroyal Industries, Inc. 15.3.9 Medi GmbH & Co. KG 15.3.10 Thuasne Group 15.3.11 Alcare Co., Ltd 15.3.12 Zimmer Biomet Holdings, Inc. 15.3.13 Trulife 15.3.14 Remington Products Company 15.3.15 Bird & Cronin |
Market Breakup by Product
- Lower Extremity Braces and Supports
- Spinal Braces and Supports
- Upper Extremity Braces and Supports
Market Breakup by Type
- Soft and Elastic Braces and Supports
- Hinged Braces and Supports
- Hard and Rigid Braces and Supports
Market Breakup by Application
- Ligament Injury
- Preventive Care
- Post-Operative Rehabilitaion
- Osteoarthritis
- Others
Market Breakup by End-User
- Orthopedic Clinics
- Hospitals and Surgical Centers
- Over-the-Counter (OTC) Platforms
- Others
Market Breakup by Region
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
OPHTHALMIC LASERS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 106 pages | Published: 04-08-2019 |
- Healthcare
- IMARC GROUP
- 106 pages
- Published: 04-08-2019
The global ophthalmic lasers market was worth US$ 1,069 Million in 2018. The ophthalmic laser is a medical equipment that is used to operate on ophthalmic disorders and to treat cells present in the eye. The laser beam emitted from the device is a source of clear and monochromatic light that focuses on a particular spot in the eye. It is an effective tool for clinical and therapeutic procedures. Ophthalmic lasers are used for a variety of disorders and procedures such as cataract surgery, posterior capsulotomy, retinal photocoagulation, laser trabeculoplasty, laser iridotomy, etc.
The rising demand for economical, harmless and pain-free ophthalmic laser therapies coupled with a rising global geriatric population represents key factors driving this market. The increasing incidences of chronic and communicable eye diseases has increased the consumer awareness for laser treatments in order to prevent blindness and visual impairment. Additionally, the demand for ophthalmic lasers is catalyzed by the growing geriatric population suffering from old-age related problems such as diabetic eye diseases, glaucoma, cataract, etc. Moreover, technological progression in procedures has enhanced the accuracy and success rates of ophthalmic laser surgeries, further creating a positive impact on the market. Furthermore, factors such as extensive R&D in the laser eye-care segment, escalating concerns for vision-health management, increasing number of ophthalmic clinics and hospitals, etc, are also contributing significantly to the growth of the market. Looking forward, IMARC Group expects the market to reach a value of US$ 1,353 Million by 2024, registering a CAGR of around 4% during 2019-2024.
Report Coverage:
Historical, Current and Future Market Trends
Market Breakup by Product:
Diode Lasers
Femtosecond Lasers
Excimer Lasers
Nd: YAG Lasers
SLT Lasers
Others
Market Breakup by Indication:
Glaucoma
Cataract Removal
Refractive Error Corrections
Diabetic Retinopathy
Others
Market Breakup by End-User:
Hospitals
Eye Clinics
Others
Market Breakup by Region:
North America
Asia Pacific
Europe
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Alcon Laboratories Inc. (Novartis AG), Johnson & Johnson Surgical Vision Inc., Bausch + Lomb, Ellex Medical Lasers Limited, IRIDEX Corporation, Lumenis, Topcon, A.R.C. Laser, Abbott Medical Optics, Calmar Laser, Carl Zeiss Meditec, Meridian, Nidek, Optos, Quantel, Ziemer, etc.
Key Questions Answered in This Report:
- How has the global ophthalmic lasers market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global ophthalmic lasers industry?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global ophthalmic lasers industry?
- What are the key driving factors and challenges in the global ophthalmic lasers industry?
- What is the structure of the global ophthalmic lasers industry and who are the key players?
- What is the degree of competition in the global ophthalmic lasers industry?
- What are the profit margins in the global ophthalmic lasers industry?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Ophthalmic Lasers Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product 5.4 Market Breakup by Indication 5.5 Market Breakup by End-User 5.6 Market Breakup by Region 5.7 Market Forecast 6 Market Breakup by Product 6.1 Diode Lasers 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Femtosecond Lasers 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Excimer Lasers 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Nd:YAG Lasers 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 SLT Lasers 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Others 6.6.1 Market Trends 6.6.2 Market Forecast 7 Market Breakup by Indication 7.1 Glaucoma 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Cataract Removal 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Refractive Error Corrections 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Diabetic Retinopathy 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Other 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by End-User 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Eye Clinics 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Asia Pacific 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Europe 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Middle East and Africa 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Latin America 9.5.1 Market Trends 9.5.2 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Alcon Laboratories Inc. (Novartis AG) 14.3.2 Johnson & Johnson Surgical Vision Inc. 14.3.3 Bausch + Lomb 14.3.4 Ellex Medical Lasers Limited 14.3.5 IRIDEX Corporation 14.3.6 Lumenis 14.3.7 Topcon 14.3.8 A.R.C. Laser 14.3.9 Abbott Medical Optics 14.3.10 Calmar Laser 14.3.11 Carl Zeiss Meditec 14.3.12 Meridian 14.3.13 Nidek 14.3.14 Optos 14.3.15 Quantel 14.3.16 Ziemer |
Market Breakup by Product
- Diode Lasers
- Femtosecond Lasers
- Excimer Lasers
- Nd:YAG Lasers
- SLT Lasers
- Others
Market Breakup by Indication
- Glaucoma
- Cataract Removal
- Refractive Error Corrections
- Diabetic Retinopathy
- Other
Market Breakup by End-User
- Hospitals
- Eye Clinics
- Others
Market Breakup by Region
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
MINIMALLY INVASIVE SURGERY MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 106 pages | Published: 04-08-2019 |
- Healthcare
- IMARC GROUP
- 106 pages
- Published: 04-08-2019
The global minimally invasive surgery market was worth US$ 36.5 Billion in 2018. A minimally invasive surgery utilizes surgical techniques that limit the size and number of cuts or incisions during an operation with the help of small tools, cameras and lights. This procedure is much safer in nature as compared to traditional open surgery as it results in fewer complications, quicker recovery, minimal blood loss, good results and shorter hospital stays. Due to these factors, these surgeries are gaining popularity amongst surgeons as well as patients all over the world. They are mostly being used for cardiothoracic, orthopedic, vascular and neurological surgical procedures. Looking forward, IMARC Group expects the market to reach US$ 58.2 Billion by 2024, expanding at a CAGR of around 8% during 2019-2024.
Market Drivers:
Rising geriatric population across the globe coupled with the increasing prevalence of arthritis, cancer and cardiovascular diseases is impelling the demand for these surgeries as they are associated with fewer risks and minimal procedural trauma.
These procedures are now being performed with the help of robotic technology which allows precise control over the surgery. This has resulted in higher success rates of these procedures which, in turn, is bolstering the market growth.
Technologically advanced products, such as narrow-band imaging endoscopes, and HD cameras have been introduced by manufacturers which are creating a positive outlook for the industry worldwide.
As these surgeries aid in reducing post-operative pain and offer fast recovery, numerous surgeons are now performing them in their own clinics. Therefore, the rising number of physician-owned ambulatory surgical centers (ASCs) is providing impetus to the market growth.
Report Cover:
Historical, Current and Future Market Trends
Market Breakup by Product Type:
Surgical Devices
Laparoscopy Devices
Monitoring and Visualization Devices
Market Breakup by Application:
Bariatric Surgery
Breast Surgery
Cardiac Surgery
Cosmetic Surgery
Gastrointestinal Surgery
Gynaecological Surgery
Orthopedics and Spine Surgery
Thoracic Surgery
Others
Market Breakup by End-User:
Hospitals
Clinics
Others
Market Breakup Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Zimmer Biomet Inc., Medtronic Inc., GE Healthcare, Intuitive, Eximis Surgical, Stryker Corporation, Arthrex, B. Braun, Bauer Medical, Check-Cap, Cook Medical, OmniGuide, Inc., Orthofix Holdings,Inc, Pentax, Philips Healthcare, RF System, Smith & Nephew, TransEnterix, Virtual Ports, etc.
Key Questions Answered in This Report:
- How has the global minimally invasive surgery market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global minimally invasive surgery industry?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global minimally invasive surgery industry?
- What are the key driving factors and challenges in the global minimally invasive surgery industry?
- What is the structure of the global minimally invasive surgery industry and who are the key players?
- What is the degree of competition in the global minimally invasive surgery industry?
- What are the profit margins in the global minimally invasive surgery industry?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Minimally Invasive Surgery Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product Type 5.4 Market Breakup by Application 5.5 Market Breakup by End-User 5.6 Market Breakup by Region 5.7 Market Forecast 6 Market Breakup by Product Type 6.1 Surgical Devices 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Laparoscopy Devices 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Monitoring and Visualization Devices 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Application 7.1 Bariatric Surgery 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Breast Surgery 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Cardiac Surgery 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Cosmetic Surgery 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Gastrointestinal Surgery 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Gynaecological Surgery 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Orthopedics and Spine Surgery 7.7.1 Market Trends 7.7.2 Market Forecast 7.8 Thoracic Surgery 7.8.1 Market Trends 7.8.2 Market Forecast 7.9 Others 7.9.1 Market Trends 7.9.2 Market Forecast 8 Market Breakup by End-User 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Clinics 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Europe 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Asia Pacific 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Middle East and Africa 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Latin America 9.5.1 Market Trends 9.5.2 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Zimmer Biomet Inc. 14.3.2 Medtronic Inc. 14.3.3 GE Healthcare 14.3.4 Intuitive 14.3.5 Eximis Surgical 14.3.6 Stryker Corporation 14.3.7 Arthrex 14.3.8 B. Braun 14.3.9 Bauer Medical 14.3.10 Check-Cap 14.3.11 Cook Medical 14.3.12 OmniGuide, Inc. 14.3.13 Orthofix Holdings,Inc 14.3.14 Pentax 14.3.15 Philips Healthcare 14.3.16 RF System 14.3.17 Smith & Nephew 14.3.18 TransEnterix 14.3.19 Virtual Ports |
Market Breakup by Product Type
- Surgical Devices
- Laparoscopy Devices
- Monitoring and Visualization Devices
Market Breakup by Application
- Bariatric Surgery
- Breast Surgery
- Cardiac Surgery
- Cosmetic Surgery
- Gastrointestinal Surgery
- Gynaecological Surgery
- Orthopedics and Spine Surgery
- Thoracic Surgery
- Others
Market Breakup by End-User
- Hospitals
- Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America